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The aim of this study was to determine the best combination of cryoprotectant (Ethylene glycol, EG), dimethyl sulfoxide (DMSO) and 
propanediol (PrOH) and carrier system (hemistraw and cryotop) in improving ewe oocytes viability during cryopreservation. Oocytes with multi 
layers of compact cumulus cells were colleted from abbatoir and matured in TCM 199 medium supplemented with 10% fetal calf serum for 24-
26 h at 38.5 C under 5% CO2 in the air. Matured oocyte was divided into six parts and vitrified in three different vitrification solutions; (i) 17% 
EG+17% DMSO with hemistraw as carrier system, (ii) 34% EG with hemistraw as carrier system, (iii) 17% EG+17% PrOH in hemistraw (iv), 
17% EG+17% DMSO with cryotop as carrier system (v), 34% EG with cryotop as carrier system (vi), and 17% EG+17% PrOH in cryotop. 
Oocytes were cryopreserved for one week before revived and evaluated for viability. The result showed that oocytes vitrified in media containing 
EG and DMSO in cryotop had the highest viability (88.16%) compared to media containing EG only or EG and PrOH (70.95% and 68.76%, 
respectively) (P<0.05). Moreover, oocytes viability that vitrified using cryotop and hemistraw as carrier system were not significantly different. 
The present results indicated that vitrification using combination of EG and DMSO as permeable cryoprotectant and cryotop as carrier system 
was the best system to maintain oocyte viability after vitrification-warming. 
____________________________________________________________________________________________________________________ 




Tujuan dari penelitian ini adalah menentukan kombinasi cryoprotectant (ethylene glycol (EG), dimethyl sulfoxide (DMSO) dan propanediol 
(PrOH) dan sistem carrier (Hemistraw dan cryotop) untuk kriopreservasi dengan menggunakan oosit domba. Oosit yang mempunyai beberapa 
lapisan sel cumulus diperoleh dari ovarium yang dikoleksi dari Rumah Potong Hewan dimaturasi secara in vitro dalam media TCM 199 yang 
disuplementasi dengan 10% fetal bovine serum selama 24-26 jam di dalam inkubator dengan suhu 38,5 C dan 5% CO2. Oosit yang telah 
matang dibagi menjadi enam bagian, selanjutnya divitrifikasi dalam tiga larutan berbeda (i) 17% EG+17% DMSO dengan hemistraw sebagai 
sistem carrier (ii) 34% EG dengan hemistraw sebagai sistem carrier(iii) 17% EG+17% PrOH di hemistraw (iv) 17% EG+17% DMSO dengan 
cryotop sebagai sistem carrier(v) 34% EG dengan cryotop sebagai sistem carrier(vi) 17% EG+17% PrOH dalam cryotop. Oocytes disimpan 
selama satu minggu, kemudian dicairkan kembali dan dievaluasi untuk melihat viabilitasnya. Hasil menunjukkan bahwa viabilitas oosit yang 
divitrifikasi pada media yang mengandung EG dan DMSO dalam cryotop memiliki viabilitas tertinggi (88,16%) dibandingkan dengan media 
yang hanya mengandung EG atau atau EG dan PrOH (masing-masing 70,95% dan 68,76%) (P<0,05). Selain itu, viabilitas oosit yang 
menggunakan cryotop dan hemistraw sebagai sistem system carrier tidak berbeda secara signifikan. Hasil ini menunjukkan bahwa vitrifikasi 
menggunakan kombinasi EG+DMSO sebagai krioprotektan dan cryotop sebagai sistem carrier adalah sistem terbaik untuk mempertahankan 
viabilitas oosit pasca vitrifikasi. 
____________________________________________________________________________________________________________________ 





Vitrification is a technique to maintain fertility from 
a patient who undergoing gonadal-toxic chemotherapy 
or radiotherapy and ovariohysterectomy by freezing 
and storing their oocytes in Assisted Reproduction 
Technologies (ART) (Cobo et al., 2013). Oocyte 
vitrification is also applied for women who wish to 
delay having offspring by freezing their oocytes during 
reproductive age (Daniluk and Koert, 2017) and to be 
used in the future. In the field of veterinary medicine 
and animal husbandry, vitrification has been used to 
guarantee the availability of gamete cells for in vitro 
embryos production, safeguard of wildlife or 
endangered species (Comizzoli, 2016), and 
cryobanking of farm animals genetic (Mara et al., 
2013). 
Vitrification is known to establish a glass-like solid 
state during the cooling process. The successful rate of 
oocyte vitrification is still limited (Vajta, 2000; Paulini 
et al., 2014). Vitrification needs a high concentration of 
cryoprotectant and rapid cooling rate to prevent the 
formation both of intracellular and extracellular ice 
crystal. One way to reach the high cooling rate is by 
using a carrier system that able to minimize the 
cyryopotectant volume. Some types of carriers that 
have been used for vitrification of oocytes are 
cryoloop, cryotop, fibreplug, and electron microscope 
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grid (Bartolac et al., 2015). The difference in the 
volume of cryoprotectant in vitrification will result the 
different degree of viability of the oocyte after 
vitrification-warming cycle.  
The disadvantage of using the high concentration of 
cryoprotectant for oocyte vitrification is the cytotoxic 
effect that damages the structure of oocyte organelles. 
Various methods have been developed to enhance the 
efficacy of oocyte vitrification, for example by 
evaluating the type and concentration of 
cryoprotectants (Aye et al., 2010; Lee et al., 2010), 
combining one or more intracellular and extracellular 
cryoprotectants to reduce the cytotoxic effect, and 
reducing the freezing point when the cells are exposed 
to the vitrification solution (Vatja and Kuwayama, 
2006).  
Three major permeating cryoprotectants that used in 
commercial vitrification media are dimethyl sulfoxide 
(DMSO), 1,2 propanediol (PrOH), and ethylene glycol 
(EG). All of cryoprotectants have a potency to degrade 
or alter over preservation time and most of these 
degradation products are also toxic. EG is 
cryoprotectant that less toxic and low molecular 
weight. EG is mostly used as cryoprotectants for 
cryopreservation of embryos and also applied for 
cryopreservation of oocytes (Gordon, 2004). The low 
molecular weight of EG (62.07 g/mol) gives a 
favorable effect of higher permeability.  
The aim of this study was to evaluate the effects of 
EG in combination with other cryoprotectants as 
vitrification solution and two different carrier systems 
towards oocyte viability after vitrification-warming 
cycle. Sheep oocytes were used as models for oocytes 
vitrification, and the result can be applied for oocytes 
cryopreservation in a human fertility clinic or embryo 
transfer program in veterinary medicine. 
 
MATERIALS AND METHODS 
 
Oocytes Collection 
Ovaries were collected from a local abattoir and 
brought to the laboratory in physiological saline (0.9% 
NaCl) at 25-30 C within 4 hours. Oocytes were 
collected by slicing method in PBS media 
supplemented with 5% fetal bovine serum (FBS). The 
cumulus-oocyte-complexes (COCs) with at least 3-4 
layers of cumulus cells and having homogeneous 
cytoplasm were washed twice in DPBS supplemented 
with gentamycin. The COCs were suspended in DPBS 
with 10% FBS and antibiotic-gentamycin. Oocyte 
selection and manipulation were performed at room 
temperature. 
 
In Vitro Maturation 
Five to ten COCs from all grades were introduced to 
50 µL maturation media and covered by mineral oil 
(Sigma, USA) in a sterile petri dish. The COCs were 
cultured for 24 hours in the incubator (5% CO2; 90% 
humidity; 38 C). Each of COCs was examined under a 
stereomicroscope and evaluated for maturation based on 
extrusion of the first polar body (Widyastuti et al., 2017a). 
Vitrification of Oocytes 
Oocytes with first polar body extrusion were divided 
into six groups that used cryotop and homemade 
hemistraw as a carrier system. Each of group was 
transferred into three treatments; (i) vitrified with 17% 
EG+17% DMSO, (ii) vitrified with 34% EG, (iii) 
vitrified with 17% EG+17% PrOH. All vitrification 
mediums were supplemented with 0.65 M sucrose and 
20% FBS in PBS. Oocytes were equilibrated in the 
solution containing a half concentration of permeable 
cryoprotectant of vitrification solution before introduced 
to vitrification solution. After 15 minutes, oocytes were 
transferred into vitrification solution for 30 seconds then 
about 6μl of vitrification solution containing oocytes was 
loaded directly into cryotop or hemistraw, exposed to 
liquid nitrogen and stored in liquid nitrogen-filled cryo 
tank (Widyastuti et al., 2017b). 
 
Warming and Evaluation of Vitrified Oocytes 
The vitrified micro drops were exposed to dilution 
medium containing 1.0 M sucrose in TCM-199 
supplemented with 20% FBS. Samples were incubated 
for 3 hours at 38.5 C under 5% CO216. The post 
warming viability of oocytes was determined by 
morphologically examinationd under an inverted 
microscope (200x). The oocytes were considered viable 
if they have spherical and symmetrical shape with no 
sign of lysis, membrane damage, swelling, or 
cytoplasm degeneration.  
 
Data Analysis 
Data were analyzed using analysis of variance 
(ANOVA). The differences between control and 
experimental group were evaluated using Tukey's HSD 
test as Post-Hoc Multiple Comparison Tests. The 
significantly different level was considered significant 
at P<0.05. 
 
RESULTS AND DISCUSSION 
 
The general steps of oocyte vitrification process are 
equilibration, vitrification, and warming. Oocytes are 
exposed to an intermediate concentration of permeable 
cryoprotectant to avoid osmotic shock and lessened the 
damaging effect during the equilibration before 
introduced to the vitrification solution and stored in the 
liquid nitrogen. The permeating cryoprotectant forms a 
hydrogen bond with phospholipid cell layer to replace 
intracellular fluid. A precise concentration of permeable 
cryoprotectant is very important, because a high 
concentration is toxic for cells, while a low concentration 
induces the forming of the intracellular and extracellular 
ice crystal. The cytotoxic and damaging effect of the 
permeable cryoprotectant can be reduced by choosing 
permeable cryoprotectant with low toxicity and or 
combining one or more permeable cryoprotectant. In our 
study, we used a high concentration of cryoprotectants 
and an extremely rapid rate of cooling to form solid state 
and prevent formation of intracellular ice crystals. The 
oocyte morphology after vitrification warming cycle is 
illustrated in Figure 1.  
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Three combinations of cryoprotectant were used as 
vitrification solution. All treatments were processed 
through the corresponding equilibration and vitrification 
solutions. The viability of oocytes that preserved in 
cryotop and hemistraw as carrier system are presented in 
Figure 2. The oocytes viability was not significantly 
different between oocytes vitrified using cryotop and 
hemistraw as a carrier system. Both carrier systems used 
in this study were similarly effective for oocytes 
vitrification. The previous study showed that the sheep 
oocytes viability was not significantly different in both 
carrier systems (Winangun et al., 2017). Both types of 
carrier are open system that allows oocytes and media 
directly contact with liquid nitrogen (Begin et al., 2013). 
The cryoprotectant volume used on both carriers was 
very small (<3 μL), so it allowed the sample to reach the 
freezing point quickly and minimized cell damage due to 
cold temperature (chilling injury) during vitrification. 
The most critical factor during freezing that induces a 
chilling injury is an intermediate zone of temperature -15 
to -60 C (Gao and Critser, 2000). Under these 
conditions, cells will begin to damage indicated by 
morphological changes such as mitochondrial, lipid and 
cytoplasmic destruction and spur abnormalities of cell 
chromosomes (Boiso et al., 2002; AlbarracÍn et al., 
2005; Gautam et al., 2008). 
The type and concentration of cryoprotectant were 
also a key factor for an oocyte vitrification successful 
rate. This experiment showed that EG alone as 
permeable cryoprotectant gave the lowest viability of 
oocyte after warming compared with the other groups. 
The highest viability of oocyte after warming was 
gained in oocytes vitrified with a combination of EG 
and DMSO (P<0.05).  
EG as permeable cryoprotectant will diffuse through 
the cell membrane and maintain the balance of 
intracellular and extracellular fluid. It can increase the 
degree of dehydration, by keeping the volume of 
intracellular water to balance (Gilmore et al., 2000). This 
agent has a small size and thus penetrates the membrane 
rapidly (Shaw and Jones, 2003). EG as single permeable 
cryoprotectant may induce shock osmotic and cytotoxic 
effect to lead biochemical damage. As the results of 
biochemical damage are the inactivation or denaturation 
of specific enzymes, damage from transmembrane ion 
pumps, and disturbance to cellular structures and 
functions caused by the direct interaction between 
cryoprotectants with proteins and biological membranes 
(Lin and Tsai, 2012). It indicated that using EG only as a 
permeable cryoprotectant was not adequate for 
vitrification solution and needs another permeable 
cryoprotectant for oocyte vitrification. 
Our results showed that combination of permeable 
cryoprotectants was advantageous for oocyte 
vitrification. It reduces the toxic and damaging effect to 
the cell, increase the viscosity of vitrification solution, 
and prevent the formation of an intracellular and 
extracellular ice crystal. The combination permeable 
cryoprotectant will act with several possible mechanisms 
during vitrification process including decreasing the 
freezing point of the vitrification solution, preventing 
oocytes damage from high electrolyte concentration and 
preventing the expose of oocytes to a high concentration 
of intra and extracellular electrolytes by linking to the 
electrolytes (Pegg, 2007).  
Based on this study, it seem that the combination of 
EG and DMSO gave the better result than a combination 
of EG and PrOH. DMSO has two a polar groups and a 
highly polar domain that make this molecule soluble in 
organic and inorganic solution. DMSO is able to 
penetrate and leave cells without significant damage and 
it was reported that vitrification solutions with DMSO 
protect embryo membrane integrity better than solutions 
without DMSO (Kartberg et al., 2008).  
Similar to this present finding, previous study also 
found that the best combination of cryoprotectants were 
 
Figure 1. Oocyte morphology typical after vitrification-warming cycle. Non-viable oocyte was (A) lysis cytoplasm, (B) shrunk 
or un-recover cytoplasm, and (C) degenerated cytoplasm with dark cytoplasm. (D) Viable oocyte was showed by normal round 
shape, clear, and smooth cytoplasm. Bar scale= 10 µm 
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EG and DMSO for vitrification of the immature buffalo 
oocytes using straw or open pulled straw methods 
(Mahmoud et al., 2010). The combination of EG and 
PROH showed the lower oocyte viability after 
vitrification and warming compared with a combination 
of EG and DMSO. It is probably due to PrOH natural 
breakdown product, formaldehyde, which is considered 
toxic to living cells. Mahdevan et al. (1998) reported 
that formaldehyde is an unavoidable bi-product during 
a production of PrOH, with each batch containing 
formaldehyde in variable amounts. Karran and Legge 
(1996) reported that the level of formaldehyde 
increased in PrOH under storage indicating a continual 




Combination of EG and DMSO as permeable 
cryoprotectant and cryotop as carrier system was the 





We thank to Kikin Winangun for providing sheep 




AlbarracÍn, J.L., R. Morató, D. Izquierdo, and T. Mogas. 2005. 
Vitrification of calf oocytes: Effects of maturation stage and 
prematuration treatment on the nuclear and cytoskeletal 
components of oocytes and their subsequent development. Mol. 
Reprod. Dev.72(2):239-249. 
Aye, M., C. Di Giorgio, M. De Mo, A. Botta, J. Perrin, and B. 
Courbiere. 2010. Assessment of the genotoxicity of three 
cryoprotectants used for human oocyte vitrification: Dimethyl 
sulfoxide, ethylene glycol and propylene glycol. Food Chem. 
Toxicol. 8(7):1905-1912. 
Bartolac, L.K., J.L. Lowe, G. Koustas, C. SjÖBlom, and C.G. 
Grupen. 2015. A comparison of different vitrification devices 
and the effect of blastocoele collapse on the cryosurvival of in 
vitro produced porcine embryos. J. Reprod. Develop. 
61(6):525-31. 
Begin, I., B. Bhatia, H. Baldassarre, A. Dinnyes, and C.L. Keefer. 
2013. Cryopreservation of goat oocytes and in vivo derived 2- to 
4-cell embryos using the cryoloop (CLV) and solid-surface 
vitrification (SSV) methods. Theriogenology. 59(8):1839-1850. 
Boiso, I., M. Marti, J. Santalo, M. Ponsa, P.N. Barri, and A. Veiga. 
2002. A confocal microscopy analysis of the spindle and 
chromosome configurations of human oocytes cryopreserved at 
the germinal vesicle and metaphase II stage. Human Reprod. 
17(7):1885-1891. 
Cobo, A., J.A. Garcia-Velasco, J. Domingo, J. Remohí, and A. 
Pellicer. 2013. Is vitrification of oocytes useful for fertility 
preservation for age-related fertility decline and in cancer 
patients? Fertil. Steril. 99(6):1485-1495. 
Comizzoli, P. 2017. Biobanking and fertility preservation for rare and 
endangered species. Anim. Reprod.14(1):30-33. 
Daniluk, J.C. and E. Koert. 2016. Childless women's beliefs and 
knowledge about oocyte freezing for social and medical reasons. 
Human Reprod .31(10):2313-2320.  
Gautam, S.K., V. Verma, P. Palta, M.S. Chauhan, and R.S. Manik. 
2008. Effect of type of cryoprotectant on morphology and 
developmental competence of in vitro-matured buffalo (Bubalus 
bubalis) oocytes subjected to slow freezing or vitrification. 
Reprod. Fertil. Dev. 20(4):490-496. 
Gao, D. and J.K. Critser. 2000. Mechanisms of cryoinjury in living 
cells. ILAR Journal. 41(4):187-196.  
Gilmore, J.A., J. Liu, E.J. Woods, A.T. Peter, and J.K. Critser. 2000. 
Cryoprotective agent and temperature effects on human sperm 
membrane permeabilities: Convergence of theoretical and 
empirical approaches for optimal cryopreservation methods. 
Human Reprod. 15(2):335-343. 
Gordon, I.R. 1994. Laboratory Production of Cattle Embryos. 2nd 
ed. CAB International, Wallingford, Oxon, UK. 
Karran, G. and M. Legge. 1996. Non-enzymatic formation of 
formaldehyde in mouse oocyte freezing mixtures. Human 
Reprod. 11(12):2681-2686. 
Kartberg, A.J., F. Hambiliki, T. Arvidsson, A. Stavreus-Evers, and P. 
Svalander. 2008. Vitrification with DMSO protects embryo 
membrane integrity better than solutions without DMSO. 
Reprod. Biomed. Online.17(3):378-384. 
Lin, C. and S. Tsai. 2012. The effect of cryopreservation on DNA 
damage, gene expression and protein abundance in vertebrate. 
Italian J. Anim. Sci.11(1):Doi.Org/10.4081/ Ijas.2012.E21. 
Lee, H.J., H. Elmoazzen, D. Wright, J. Biggers, B.R. Rueda, and Y.S. 
Heo. 2010. Ultra-rapid vitrification of mouse oocytes in low 
cryoprotectant concentrations. Reprod. BioMed Online. 
20(2):201-208.  
Mahdevan, M.M., Q. McIntosh, M.M. Miller, S.M. Breckinridge, M. 
Maris, and D.M. Moutos. 1998. Formaldehyde in cryoprotectant 
propanediol and effect on mouse zygotes. Human Reprod. 
13(4):979-982. 
Mahmoud, K.G., T.H. Scholkamy, Y.F. Ahmed, G.E. Seidel, and 
M.F. Jr. Nawito. 2010. Effect of different combinations of 
cryoprotectants on in vitro maturation of immature buffalo 
(Bubalus bubalis) oocytes vitrified by straw and open-pulled 
straw methods. Reprod. Domest. Anim. 45(4):565-571. 
 
Figure 2. Oocyte viability after vitrification-warming cycle using three different combinations of cryoprotectant in cryotop and 
hemistraw as a carrier system (The highest oocytes viability were oocytes vitrified in 17% EG+17% DMSO, but the differences were not 
statistically significant, n= 50/group; *= P<0.05) 
Rini Widyastuti et al. 
 
61 
Mara, L., S. Casu, A. Carta, and M. Dattena. 2013. Cryobanking of 
farm animal gametes and embryos as a means of conserving 
livestock genetics. Anim. Reprod. Sci.138(1-2):25-38. 
Paulini, F., R.C. Silva, J.L.J. de Paula Rôlo, and C.M. Lucci. 2014. 
Ultrastructural changes in oocytes during folliculogenesis in 
domestic mammals. J. Ovarian Res. Doi:10.1186/s13048-014-
0102-6 
Pegg, D.E. 2007. Principles of cryopreservation. Methods in Mol. 
Biol. 368:39-57. 
Shaw, J.M. and G.M. Jones. 2003. Terminology associated with 
vitrification and other cryopreservation procedures for oocytes 
and embryos. Human Reprod. Update. 9(6):583-605. 
Vajta, G. 2000. Vitrification of the oocytes and embryos of domestic 































































Vajta, G. and M. Kuwayama. 2006. Improving cryopreservation 
systems. Theriogenology. 65(1):236-244. 
Widyastuti, R., M.R.A.A. Syamsunarno, T. Saili, and A. Boediono. 
2017a. Oocyte quality and subsequent in vitro maturation of 
sheep oocyte-cumulus complex from ovary with presence and 
absence of corpus luteum. Proceedings of The Veterinary 
Medicine International Conference. Surabaya:166-174. 
Widyastuti, R., C. Khoirinaya, M.R. Ridlo, and M.R.A.A. 
Syamsunarno. 2017b. Perbandingan viabilitas oosit pasca 
vitrifikasi pada konsentrasi sukrosa yang berbeda. Majalah 
Kedokteran Bandung. 49(4):252-258. 
Winangun, K., R. Widyastuti, and M.R.A.A. Syamsunarno. 2017. 
Perbandingan viabilitas oosit domba pasca vitrifikasi dengan 
menggunakan hemistraw dan cryotop. J. Agripet. 17(2):75-80. 
